PALM BEACH, Fla., Oct. 14, 2021 /PRNewswire/ -- The last two decades have seen a great deal of progress in global legalization and regulation of cannabis, both for medical and recreational use. Nowadays, the demand for cannabis is expected to increase significantly from the arrival of cannabis-infused products. The growth of the overall CBD-infused products market is backed by the rising demand and increasing legalization of cannabis, growing application of cannabis in cancer, and health benefits offered by cannabis-infused products. Moreover, the usage of cannabis in pet food and the increasing demand for cannabis-infused drinks provide significant opportunities in this market. However, the high cost associated with CBD and stringent government regulations against cannabis in certain countries obstructs the growth of this market to some extent. A report from Meticulous Research projected that the CBD-infused products market is expected to grow at a CAGR of 45.6% from 2021 to 2028 to reach $216.8 billion by 2028. The report said, "The COVID-19 pandemic has severely impacted many economies around the globe. As a measure to control the spread of this disease and avoid its associated consequences, governments across the globe announced partial or complete lockdowns, majorly impacting many industries, but the cannabis industry is having a breakthrough moment. Since it is beneficial for COVID-19 respiratory effects, thus state and local governments are gradually accepting the value and benefits of medicinal cannabis. Thus, this factor is expected to boost the demand for CBD-infused products." Active Companies in the cannabis industry include Grove, Inc. (NASDAQ: GRVI), Trulieve Cannabis Corp. (OTCQX: TCNNF) (CSE: TRUL), Curaleaf Holdings, Inc. (OTCQX: CURLF) (CSE: CURA), Cronos Group, Inc. (NASDAQ: CRON) (TSX: CRON), Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB).